Q2 2025 Holdings
Filed 2025-08-14 | 124 holdings | $5.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Jade Biosciences Inc(JBIO) | COM NEW | 008064206 | $5.3M | 531,163 | 0.1% |
| Neuropace Inc(NPCE) | COM | 641288105 | $5.6M | 500,000 | 0.1% |
| Simulations Plus Inc(SLP) | COM | 829214105 | $6.2M | 354,089 | 0.1% |
| The Oncology Institute Inc(TOI) | COM | 68236X100 | $6.9M | 3,360,052 | 0.1% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $7.3M | 225,000 | 0.1% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $7.7M | 373,407 | 0.1% |
| Docgo Inc(DCGO) | COM | 256086109 | $7.8M | 4,941,565 | 0.1% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $9.2M | 613,665 | 0.2% |
| Integra Lifesciences Hldgs C(IART) | COM NEW | 457985208 | $9.8M | 794,865 | 0.2% |
| Omada Health Inc(OMDA) | COM | 68170A108 | $10.1M | 553,107 | 0.2% |
| Delcath SYS Inc(DCTH) | COM NEW | 24661P807 | $11.1M | 812,561 | 0.2% |
| Rxsight Inc(RXST) | COM | 78349D107 | $11.6M | 888,950 | 0.2% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $12.4M | 5,386,000 | 0.2% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $14.7M | 825,119 | 0.3% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $15.1M | 1,562,942 | 0.3% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $15.3M | 3,255,514 | 0.3% |
| Neogenomics Inc(NEO) | COM NEW | 64049M209 | $15.7M | 2,148,000 | 0.3% |
| Sionna Therapeutics Inc(SION) | COM | 829401108 | $16.8M | 970,590 | 0.3% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $16.9M | 625,000 | 0.3% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $17.0M | 542,020 | 0.3% |
| Beta Bionics Inc(BBNX) | COM | 08659B102 | $17.0M | 1,168,415 | 0.3% |
| Xeris Biopharma Holdings Inc | NOTE 8.000% 7/1 | 98422EAB9 | $17.7M | $10,500,000 | 0.3% |
| Savara Inc(SVRA) | COM | 805111101 | $18.2M | 7,964,000 | 0.3% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $18.2M | 140,000 | 0.3% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $18.2M | 6,710,429 | 0.3% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $19.0M | 2,640,215 | 0.3% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $20.1M | 1,616,778 | 0.4% |
| Ventas Inc(VTR) | COM | 92276F100 | $22.4M | 354,000 | 0.4% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $24.2M | 3,723,131 | 0.4% |
| Livanova PLC | NOTE 2.500% 3/1 | 53802LAB8 | $25.4M | $25,000,000 | 0.5% |
| Immunocore Hldgs PLC | NOTE 2.500% 2/0 | 45258DAB1 | $25.8M | $30,000,000 | 0.5% |
| Embecta Corp(EMBC) | COMMON STOCK | 29082K105 | $26.6M | 2,749,712 | 0.5% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $27.1M | 2,067,320 | 0.5% |
| Moderna Inc(MRNA) | COM | 60770K107 | $27.6M | 1,000,000 | 0.5% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $28.5M | 653,000 | 0.5% |
| Phreesia Inc(PHR) | COM | 71944F106 | $28.9M | 1,014,577 | 0.5% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $28.9M | 686,931 | 0.5% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $29.0M | 3,855,552 | 0.5% |
| Lantheus Hldgs Inc | NOTE 2.625%12/1 | 516544AB9 | $32.1M | $25,255,000 | 0.6% |
| Pharvaris N V(PHVS) | COM | N69605108 | $35.5M | 2,017,464 | 0.6% |
| Conmed Corp(CNMD) | COM | 207410101 | $36.5M | 700,271 | 0.7% |
| Tandem Diabetes Care Inc | NOTE 1.500% 3/1 | 875372AD6 | $38.5M | $40,000,000 | 0.7% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $42.0M | 4,692,000 | 0.8% |
| Envista Holdings Corporation(NVST) | COM | 29415F104 | $43.3M | 2,215,845 | 0.8% |
| Certara Inc(CERT) | COM | 15687V109 | $45.9M | 3,926,099 | 0.8% |
| Enhabit Inc(EHAB) | COM | 29332G102 | $46.1M | 4,779,864 | 0.8% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $47.3M | 145,000 | 0.9% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $48.7M | 919,403 | 0.9% |
| BIO RAD Labs Inc(BIO) | CL A | 090572207 | $54.6M | 226,070 | 1.0% |
| Baxter Intl Inc(BAX) | COM | 071813109 | $58.2M | 1,923,100 | 1.1% |